Improving life for those who suffer most from type 1 diabetes
A transplant procedure given only to those with Type 1 diabetes who pass out repeatedly from low blood sugar levels, or hypos, is likely to become much more effective as a result of a discovery made by a group of Australian researchers.
Islet transplants (the transplant of islets from the pancreas, which contain insulin-producing cells) are not given lightly because recipients must take immunosuppressive drugs for the rest of their lives. As a result, transplant recipients are generally people who cannot regulate their blood sugar levels, and who lapse into comas, often without warning.
However, many islets die within a week of transplantation, and most patients have to go back on at least some insulin within 2-5 years.
Associate Professor Jenny Gunton, from Sydneys Garvan Institute of Medical Research and Westmead Hospital, together with the Westmead Islet Transplant Program, has discovered that treating islets prior to transplantation with a drug that boosts production of the HIF-1 alpha protein (a master regulator of cell survival) significantly improves the survival of human islets in mouse recipients. Her findings are published in Cell Transplantation, now online.
I work with the islet transplant team at Westmead Hospital, and weve been trying to figure out a way of improving outcomes for people who receive islet transplants, she said.
Isolating islets from a donor pancreas exposes them to lack of oxygen, and islets suffer a lot of damage even from temporary low amounts of oxygen. HIF-1 alpha helps cells respond to low oxygen levels, and so we predicted that boosting it would improve islet survival.
When we tested the effect of treating islets prior to transplantation with the drug deferoxamine, DFO for short, which boosts HIF-1 alpha, the results supported our prediction.
Because we had to test the effect before using it in people, we transplanted human islets into mice with some islets having been treated with DFO, and some not treated. In a minimal mass model, which approximates the human situation, we went from a 0% cure rate at a month to a 50% cure rate in a month.
In an adequate mass model, where you give the mice many more islets, mice were cured by non-DFO-treated islets. However, it took over 3 times the number of non-DFO-treated islets to cure the mice.
We also conducted an experiment which demonstrated the importance of HIF-1 alpha by engineering mice not to produce any HIF-1 alpha in their insulin-producing cells. When these non-HIFF-1 alpha islets were transplanted into diabetic mice, the recipients did very badly.
The good thing about deferoxamine is that it is already approved for human use, has been in use for well over a decade, and in our studies, we used it the normal human treatment dose.
At Westmead, weve already started using DFO to treat islets before transplantation. While its still too early to draw any conclusions, recipients are doing well. To actually test the effect in people properly, youd need to do a big randomized, placebo-controlled trial, and to get the number of people needed youd have to enrol patients from many centres world-wide clearly not an easy option.
We hope that finding a way of improving islet survival in recipients will extend the usefulness of donor pancreases meaning you could give more transplants because one pancreas might be enough for one recipient, instead of two to three pancreases for each recipient.
At the moment islet transplants are good for those people that have regular severe hypos. Even if the transplanted islets dont get the person off insulin, they stop experiencing hypos. This increases quality of life immeasurably because prior to transplantation repeat hypo sufferers are not allowed to drive and generally cant hold down a job.
We hope our finding will give these people a longer window without insulin use.
Journal reference: Cell Transplantation
Provided by Garvan Institute
- Creating 'death-defying' insulin-producing islets for transplantation Mar 13, 2012 | not rated yet | 0
- Pancreatic islets infusion for diabetes patient being readied for procedure in Japan May 16, 2012 | not rated yet | 0
- Pig to primate transplants show promise for diabetes Nov 09, 2011 | not rated yet | 0
- New technique eliminates toxic drugs in islet transplant in diabetic mice Nov 20, 2008 | not rated yet | 0
- Studies test new approaches to islet transplantation May 01, 2008 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
The Durability of Bone: Long Falls
4 hours ago I am doing a paper on the physics in Valve's Portal and got interested in the "Long Fall Boots" that prevent any damage no matter how far you fall. I...
Is energy convertible to matter?
5 hours ago Can we convert energy to matter?
Rotating electron as a dipole is this right?
8 hours ago An electron as shown by the Stern Gerlach experiment behaves like a dipole (albeit only in one of two states). I have been trying to figure out how...
Dipole term in multipole expansion
12 hours ago Hi. I'm having some difficult in understanding something about the dipole term in a multipole expansion. Griffiths writes the expansion as a sum of...
Bubbles in a Pre-Boiling/Boiling pot of water
13 hours ago How is it that bubbles form on the bottom of a surface of a pot of boiling water? I think that there is probably an elementary answer to this...
Assumptions of Griffith's fracture theory
23 hours ago Any experts on Griffith's fracture theory? I am studying the subject and I am having hard time finding out if the theory is valid for all possible...
- More from Physics Forums - Classical Physics
More news stories
Study shows that women who smoke during pregnancy increase the risk of both obesity and gestational diabetes in their da
Women who smoke during pregnancy increase the risk of both obesity and gestational diabetes, in their daughters, concludes research published in Diabetologia, the journal of the European Association for the Study of Diabet ...
Diabetes May 20, 2013 | not rated yet | 0
The number of young people diagnosed with type 2 diabetes has seen the sharpest rise over the last twenty years compared to a background of a general increase across the board, new University research has ...
Diabetes May 20, 2013 | not rated yet | 0
(Medical Xpress)—Flinders University researchers are breaking new ground in a decade-long journey to pinpoint the function of two closely related proteins.
Diabetes May 20, 2013 | 5 / 5 (2) | 0 |
(HealthDay)—Moderate aerobic exercise prevents fructose-induced hypertriglyceridemia in healthy males, according to a study published online May 14 in Diabetes.
Diabetes May 17, 2013 | 5 / 5 (1) | 0 |
A DNA variant near a digestive enzyme does not only affect risk of developing diabetes but also affects the response to treatment, an international consortium of researchers including the University of Dundee has found.
Diabetes May 17, 2013 | not rated yet | 0 |
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
15 hours ago | 4.2 / 5 (5) | 0 |
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
12 hours ago | 4.9 / 5 (11) | 0 |
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
14 hours ago | 4.6 / 5 (7) | 0 |
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
8 hours ago | 3 / 5 (2) | 0
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...
9 hours ago | 5 / 5 (4) | 0 |
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.
10 hours ago | 5 / 5 (1) | 0 |